Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Change and processes of change within interventions to promote adjustment to multiple sclerosis: Learning from patient experiences.
Cognitive Impairment Has a Strong Relation to Nonsomatic Symptoms of Depression in Relapsing-Remitting Multiple Sclerosis.
[Neuromyelitis optica.]
Transplantation of umbilical cord and bone marrow-derived mesenchymal stem cells in a patient with relapsing-remitting multiple sclerosis.
Neurological disability and its association with walking impairment in multiple sclerosis: brief review.
Cine cerebrospinal fluid imaging in multiple sclerosis.
Previous treatment influences fingolimod efficacy in relapsing-remitting multiple sclerosis: results from an observational study.
Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats.
Magnetic Resonance Spectroscopy to Assess NeuroInflammation and Neuropathic Pain.
Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells.
Synthesis of 5α-cholestan-6-one derivatives and their inhibitory activities of NO production in activated microglia: Discovery of a novel neuroinflammation inhibitor.
Nabilone as an Adjunctive to Gabapentin for Multiple Sclerosis-Induced Neuropathic Pain: A Randomized Controlled Trial.
A RARE CASE OF ODONTOGENIC PARAINFECTIOUS INTRAORBITAL OPTIC NEURITIS WITH THE ABSENCE OF CLINICAL MANIFESTATION OF ORBITAL CELLULITIS.
FDA Accepts Biologics License Application For ZINBRYTA (Daclizumab High-Yield Process) For Treatment of MS
Lysoglycerophospholipids in chronic inflammatory disorders: The PLA(2)/LPC and ATX/LPA axes.
Symptoms, Prevalence and Impact of Multiple Sclerosis in Younger Patients: A Multinational Survey.
Hyperconnectivity is a Fundamental Response to Neurological Disruption.
At Four Years, Treatment Effect Maintained in More Than Two-Thirds of Patients Who Received Genzyme’s Lemtrada in Pivotal Studies
Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses.
Pain and multiple sclerosis: pathophysiology and treatment.
Biogen Idec to acquire full rights and control of Tysabri from Elan for upfront cash and contingent payments
A case of multiple sclerosis improvement following removal of heavy metal intoxication : Lessons learnt from Matteo's case.
Multiple sclerosis and pregnancy: maternal considerations.
Structure, Size, and Solubility of Antigen Arrays Determines Efficacy in Experimental Autoimmune Encephalomyelitis.
Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned.
Pages
« first
‹ previous
…
167
168
169
170
171
172
173
174
175
…
next ›
last »